Impact of Renal Denervation on 24-Hour Ambulatory Blood Pressure
- 1 September 2014
- Vol. 64 (11) , 1071-1078
Abstract
No abstract availableKeywords
Funding Information
- Medtronic
This publication has 20 references indexed in Scilit:
- Size of blood pressure reduction from renal denervation: insights from meta-analysis of antihypertensive drug trials of 4121 patients with focus on trial design: the CONVERGE reportHeart, 2013
- Ambulatory Blood Pressure Changes After Renal Sympathetic Denervation in Patients With Resistant HypertensionCirculation, 2013
- Renal Sympathetic Denervation for Treatment of Drug-Resistant HypertensionCirculation, 2012
- Catheter‐Based Renal Denervation for Resistant Hypertension: Rationale and Design of the SYMPLICITY HTN‐3 TrialClinical Cardiology, 2012
- Addition of Spironolactone in Patients With Resistant Arterial Hypertension (ASPIRANT)Hypertension, 2011
- Divergent Results Using Clinic and Ambulatory Blood PressuresHypertension, 2010
- Prognostic significance of visit-to-visit variability, maximum systolic blood pressure, and episodic hypertensionThe Lancet, 2010
- Recruitment to a Clinical Trial Improves Glycemic Control in Patients With DiabetesDiabetes Care, 2007
- Ambulatory Blood-Pressure MonitoringNew England Journal of Medicine, 2006
- Morning Surge in Blood Pressure as a Predictor of Silent and Clinical Cerebrovascular Disease in Elderly HypertensivesCirculation, 2003